Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Global Market Report 2025
Request Sample Buy Now
Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : September 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Global Market Report 2025

By Component (Software, Services); By Deployment Mode (Cloud-Based, On-Premises); By Application (Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications); By End-User (Healthcare Providers, Life Sciences Companies, Payers, Other End-Users); Subsegments:; By Software (Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System); By Services (Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

• Artificial Intelligence (AI)-Driven Rare Disease Patient Finder market size has reached to $1.25 billion in 2024

• Expected to grow to $4.60 billion in 2029 at a compound annual growth rate (CAGR) of 29.7%

• Growth Driver: Increasing Acceptance Of Digital Health And Telemedicine Is Fueling The Growth Of The Market Due To Rising Patient Demand For Convenient And Accessible Healthcare Solutions

• Market Trend: Technological Advancements Are Driving Faster And More Efficient Patient Identification For Rare Disease Clinical Trials

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

An artificial intelligence (AI)-driven rare disease patient finder is a technology platform that leverages AI algorithms to identify and match patients with rare diseases for clinical trials, research studies, and personalized treatments. It analyzes diverse datasets, including medical records, genetic information, and real-world health data, to accurately locate potential patients. By improving patient identification efficiency, it accelerates research, enhances clinical trial recruitment, and supports the development of targeted therapies.

The main components of the artificial intelligence (AI)-driven rare disease patient finder are software and services. Software is a set of programs, instructions, and data that tell a computer or digital device how to perform specific tasks or functions. The various deployment modes are cloud-based and on-premises. The multiple applications involved are hospitals, clinics, research institutes, pharmaceutical companies, and others, and they are used by several end users such as healthcare providers, life sciences companies, payers, and others.

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size 2025 And Growth Rate?

The artificial intelligence (AI)-driven rare disease patient finder market size has grown exponentially in recent years. It will grow from $1.25 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 30.1%. The growth in the historic period can be attributed to increasing use of genomic sequencing, rising adoption of electronic health records, growing collaborations between pharma and artificial intelligence (AI) startups, increasing focus on early disease detection, and rising availability of real-world evidence.

What Is The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Growth Forecast?

The artificial intelligence (AI)-driven rare disease patient finder market size is expected to see exponential growth in the next few years. It will grow to $4.60 billion in 2029 at a compound annual growth rate (CAGR) of 29.7%. The growth in the forecast period can be attributed to increasing integration of multimodal data analytics, rising adoption of artificial intelligence (AI)-powered clinical decision support systems, growing use of wearable and remote monitoring devices, increasing investment in patient-centric healthcare platforms, and rising focus on predictive analytics for rare disease detection. Major trends in the forecast period include advancements in natural language processing for unstructured medical data, integration of federated learning for secure patient data sharing, technology-enabled multiomics data analysis, developments in synthetic data generation for rare disease modeling, and advancements in artificial intelligence (AI)-driven digital biomarkers.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Segmented?

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications

4) By End-User: Healthcare Providers, Life Sciences Companies, Payers, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

What Is Driving The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market? Increasing Acceptance Of Digital Health And Telemedicine Is Fueling The Growth Of The Market Due To Rising Patient Demand For Convenient And Accessible Healthcare Solutions

The increasing acceptance of digital health and telemedicine is expected to propel the growth of the artificial intelligence (AI)-driven rare disease patient finder market going forward. Digital health is the use of technology, software, and electronic tools to monitor, manage, and improve health and wellness. Telemedicine is the delivery of healthcare services remotely using telecommunications technology, such as video calls, mobile apps, and online platforms. The increasing acceptance of digital health and telemedicine is due to patients and providers seeking convenient, time-saving, and accessible healthcare solutions. Artificial intelligence (AI)-driven rare disease patient finder supports digital health and telemedicine by accurately identifying patients, enabling remote monitoring, timely virtual consultations, and personalized care. For instance, in February 2023, according to a survey conducted by Rock Health, a US-based health technology company, in a survey of 8,014 respondents, 76% of people over the age of 55 have used telemedicine, and 80% of all respondents reported having accessed care via telemedicine at some point in their lives, up 8% from 72% in 2021. Therefore, the increasing acceptance of digital health and telemedicine is driving the growth of the artificial intelligence (AI)-driven rare disease patient finder industry.

Who Are The Major Players In The Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

Major companies operating in the artificial intelligence (AI)-driven rare disease patient finder market are UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., and RareSum Inc.

What Are The Key Trends Of The Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market? Technological Advancements Are Driving Faster And More Efficient Patient Identification For Rare Disease Clinical Trials

Major companies operating in the AI-driven rare disease patient finder market are focusing on developing technological advancements, such as precision patient recruitment solutions, to enhance the accuracy, speed, and efficiency of identifying eligible patients for rare disease clinical trials while reducing recruitment timelines and improving trial success rates. A precision patient recruitment solution is a technology-driven approach that uses advanced algorithms and real-world data to accurately identify and engage patients who meet specific clinical trial eligibility criteria. For instance, in April 2024, Citeline, a US-based business intelligence and data analytics company, launched Citeline PatientMatch. The platform combines advanced algorithms with comprehensive real-world data, including lab results, biomarkers, and electronic medical records from over 400 hospitals and health systems, to help sponsors and investigators identify eligible patients for clinical trials in a timely and efficient manner, streamline enrollment, and support diverse and complex study protocols across multiple therapeutic areas.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market? Omda Acquires Dermicus AB To Strengthen AI-Driven Medical Imaging Portfolio

In November 2022, Norstella, a US-based life sciences technology company that uses artificial intelligence (AI) to help clinical trial planning for hard-to-recruit patient populations such as those with rare diseases, merged with Citeline for $5 billion. With this merger, Norstella aims to strengthen its position as a leading global pharmaceutical technology company by integrating Citeline’s clinical trial intelligence and patient recruitment capabilities to support drug development and commercialization. Citeline Inc. is a US-based pharmaceutical intelligence solutions provider that uses artificial intelligence (AI)-driven tools, most notably its NorstellaLinQ product, to find and target rare disease patient populations.

What Is The Regional Outlook For The Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

North America was the largest region in the artificial intelligence (AI)-driven rare disease patient finder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

The artificial intelligence (AI)-driven rare disease patient finder market consists of revenues earned by entities by providing services such as clinical trial recruitment, patient identification, electronic health record (EHR) data mining, natural language processing (NLP), and real-world evidence (RWE) analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-driven rare disease patient finder market also includes sales of predictive analytics tools, natural language processing engines, machine learning models, data integration platforms, electronic health record connectors, genomic data analyzers, patient matching engines, clinical decision support tools, and real-world data aggregators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Industry?

The artificial intelligence (ai)-driven rare disease patient finder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-driven rare disease patient finder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence AI Driven Rare Disease Patient Finder Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.62 billion
Revenue Forecast In 2034 $4.60 billion
Growth Rate CAGR of 30.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Component, Deployment Mode, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., and RareSum Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Characteristics

3. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Trends And Strategies

4. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Growth Rate Analysis

5.4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Segmentation

6.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software

Services

6.2. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cloud-Based

On-Premises

6.3. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Research Institutes

Pharmaceutical Companies

Other Applications

6.4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healthcare Providers

Life Sciences Companies

Payers

Other End-Users

6.5. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electronic Data Capture

Data Management Platform

Analytics And Reporting Tools

Patient Engagement Tools

Clinical Trial Management System

6.6. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Implementation And Integration

Training And Support

Data Hosting And Security

Consulting Services

Maintenance And Upgrades

7. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

8.1. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

9.1. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

9.2. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

10.1. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

11.1. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

11.2. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

12.1. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

13.1. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

14.1. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

14.2. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

15.1. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

15.2. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

16.1. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

17.1. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

18.1. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

19.1. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

20.1. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

21.1. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

21.2. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

22.1. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

23.1. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

23.2. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

24.1. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

24.2. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

25.1. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

25.2. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

26.1. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

26.2. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

27.1. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

28.1. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

28.2. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

29.1. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

29.2. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Landscape

30.2. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Company Profiles

30.2.1. UnitedHealth Group Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Dassault Systèmes SE Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GeneDx Holdings Corp. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. HealthVerity Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ConcertAI Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Other Major And Innovative Companies

31.1. Komodo Health Inc.

31.2. Unlearn.AI Inc.

31.3. Antidote Technologies Inc.

31.4. Healx Ltd.

31.5. FDNA Inc.

31.6. Saventic Health Sp. z o.o.

31.7. Digital Pharma Lab SAS

31.8. AnnieGuard Ltd.

31.9. Rapid Innovation Labs Inc.

31.10. Sqilline EOOD

31.11. TrialX Inc.

31.12. enGenome Srl

31.13. EveryCure Inc.

31.14. ThinkGenetic Inc.

31.15. RareSum Inc.

32. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

34. Recent Developments In The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

35. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: UnitedHealth Group Incorporated Financial Performance
  • Table 78: Dassault Systèmes SE Financial Performance
  • Table 79: GeneDx Holdings Corp. Financial Performance
  • Table 80: HealthVerity Inc. Financial Performance
  • Table 81: ConcertAI Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: UnitedHealth Group Incorporated Financial Performance
  • Figure 78: Dassault Systèmes SE Financial Performance
  • Figure 79: GeneDx Holdings Corp. Financial Performance
  • Figure 80: HealthVerity Inc. Financial Performance
  • Figure 81: ConcertAI Inc. Financial Performance

Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Read More About Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Automotive Films Market 2023 – By Film Type (Automotive Films Window Film, Paint Protection Films (PPF), Wrap Film), By Vehicle Type (Passenger, Commercial), By Application (Interior, Exterior ), By Material Type (Dyed, ...

View Report

Tax Management Market 2023 – By Component (Software, Services), By Deployment Mode (Cloud, On-Premises), By Vertical (Corporate Banking Financial Services And Insurance (BFSI), Information Technology (IT) And Telecom, Ma...

View Report

Physical Security Market 2025 - By Component (Systems, Services), By Organization Size (Small And Medium-Sized Enterprises (SMEs), Large Enterprises), By End User (Transportation, Government, Banking And Finance, Utility...

View Report

Crohn's Disease (CD) Treatment Global Market Report 2025 – By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Route of Administration (Oral, Injectable), By Distributio...

View Report

Pulse Oximeter Global Market Report 2025 – By Product Type (Fingertip, Handheld, Wrist-worn, Table-Top And Bedside), By Technology (Conventional, Connected), By Age Group (Adult, Pediatric), By End-User (Hospitals And Cl...

View Report

Essential Oils Global Market Report 2025 – By Type (Orange Oil, Lemon Oil, Lime Oil, Peppermint Oil, Corn mint Oil, Citronella Oil, Spearmint Oil, Geranium Oil, Clove Leaf Oil, Eucalyptus Oil), By Method of Extraction (D...

View Report

Tankless Water Heater Global Market Report 2025 – By Type (Condensing, Non-Condensing), By Energy Source (Electric, Gas), By Application (Residential, Commercial) – Impact of Tariff and Trade War on Market Size, Growth, ...

View Report

Frequently Asked Questions

An artificial intelligence (AI)-driven rare disease patient finder is a technology platform that leverages AI algorithms to identify and match patients with rare diseases for clinical trials, research studies, and personalized treatments. It analyzes diverse datasets, including medical records, genetic information, and real-world health data, to accurately locate potential patients. By improving patient identification efficiency, it accelerates research, enhances clinical trial recruitment, and supports the development of targeted therapies. For further insights on this market, request a sample here

The market major growth driver - Increasing Acceptance Of Digital Health And Telemedicine Is Fueling The Growth Of The Market Due To Rising Patient Demand For Convenient And Accessible Healthcare Solutions. For further insights on this market, request a sample here

The artificial intelligence (AI)-driven rare disease patient finder market size has grown exponentially in recent years. It will grow from $1.25 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 30.1%. The growth in the historic period can be attributed to increasing use of genomic sequencing, rising adoption of electronic health records, growing collaborations between pharma and artificial intelligence (AI) startups, increasing focus on early disease detection, and rising availability of real-world evidence. The artificial intelligence (AI)-driven rare disease patient finder market size is expected to see exponential growth in the next few years. It will grow to $4.60 billion in 2029 at a compound annual growth rate (CAGR) of 29.7%. The growth in the forecast period can be attributed to increasing integration of multimodal data analytics, rising adoption of artificial intelligence (AI)-powered clinical decision support systems, growing use of wearable and remote monitoring devices, increasing investment in patient-centric healthcare platforms, and rising focus on predictive analytics for rare disease detection. Major trends in the forecast period include advancements in natural language processing for unstructured medical data, integration of federated learning for secure patient data sharing, technology-enabled multiomics data analysis, developments in synthetic data generation for rare disease modeling, and advancements in artificial intelligence (AI)-driven digital biomarkers. For further insights on this market, request a sample here

The artificial intelligence (AI)-driven rare disease patient finder market covered in this report is segmented as
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications
4) By End-User: Healthcare Providers, Life Sciences Companies, Payers, Other End-Users Subsegments:
1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System
2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades For further insights on this market, request a sample here

North America was the largest region in the artificial intelligence (AI)-driven rare disease patient finder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-driven rare disease patient finder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the artificial intelligence (AI)-driven rare disease patient finder market are UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., and RareSum Inc. For further insights on this market, request a sample here.

Major trends in this market include Technological Advancements Are Driving Faster And More Efficient Patient Identification For Rare Disease Clinical Trials For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top